However, When quite a few insiders buy shares, as it happened in Inogen, Inc.'s (NASDAQ:INGN) case, it's fantastic news for shareholders. While insider transactions are not the most important thing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Inogen beat Q4 earnings and revenue estimates, citing strong B2B demand. Analysts see potential but flag supply challenges and restructuring risks. Inogen, Inc. (NASDAQ: INGN) is well-poised for ...

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

Inogen, Inc. INGN recently announced a strategic ... The collaboration with Yuwell is beneficial for INGN stock price as it strengthens the company's global presence, especially in high-growth ...

Inogen’s share price performance since my last update has been volatile to say the least. The shares traded to (and slightly above) my $12 fair value, but each time they ran up, they came ...

GOLETA, Calif., March 20, 2025--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced ...

Inogen stock opened at $9.91 on Monday. The company has a market cap of $236.04 million, a price-to-earnings ratio of -4.40 and a beta of 1.02. The firm’s fifty day moving average is $10.17 and ...

16:31 EST Inogen (INGN) sees Q1 revenue $79M-$81M, one estimate $78.1M See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze, and streamline your search for ...